DHT, synthesized from testosterone by the enzyme 5α-reductase, exhibits higher androgenic potency, stabilizing and activating AR transcriptional activity, thereby promoting the pathogenesis of BPH in men [23,24]. Here, AR is linked to benign prostatic hyperplasia.